97 related articles for article (PubMed ID: 22705356)
21. MDM2 splice variants predominantly localize to the nucleoplasm mediated by a COOH-terminal nuclear localization signal.
Schuster K; Fan L; Harris LC
Mol Cancer Res; 2007 Apr; 5(4):403-12. PubMed ID: 17426254
[TBL] [Abstract][Full Text] [Related]
22. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53 gene in oral squamous cell carcinoma and its relation with clinical and pathological parameters and prognosis of patients.
Mao C; Lu Y; Lai Q; Xia Y; Yang C
Chin Med Sci J; 1995 Dec; 10(4):199-203. PubMed ID: 8745578
[TBL] [Abstract][Full Text] [Related]
24. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
25. Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
Huun J; Gansmo LB; Mannsåker B; Iversen GT; Øvrebø JI; Lønning PE; Knappskog S
BMC Cell Biol; 2017 Apr; 18(1):17. PubMed ID: 28415963
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
27. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
Zhang J; Liu H; Li S; Gu C
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
[TBL] [Abstract][Full Text] [Related]
28. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
29. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers.
Lin SC; Liu CJ; Ko SY; Chang HC; Liu TY; Chang KW
J Pathol; 2005 Aug; 206(4):417-22. PubMed ID: 15906274
[TBL] [Abstract][Full Text] [Related]
30. Abnormal cell-cycle expression of the proteins p27, mdm2 and cathepsin B in oral squamous-cell carcinoma infected with human papillomavirus.
Cristina Mazon R; Rovigatti Gerbelli T; Benatti Neto C; de Oliveira MR; Antonio Donadi E; Guimarães Gonçalves MA; Garcia Soares E; Patrícia Klay C; Tersariol I; Aparecida Pinhal M; Resende L; Pienna Soares C
Acta Histochem; 2011 Feb; 113(2):109-16. PubMed ID: 19811804
[TBL] [Abstract][Full Text] [Related]
31. Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma.
Koch FP; Kämmerer PW; Kämmerer P; Al-Nawas B; Brieger J
Oral Oncol; 2010 Feb; 46(2):128-33. PubMed ID: 20060357
[TBL] [Abstract][Full Text] [Related]
32. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.
Sakai E; Tsuchida N
Oncogene; 1992 May; 7(5):927-33. PubMed ID: 1570156
[TBL] [Abstract][Full Text] [Related]
33. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
[TBL] [Abstract][Full Text] [Related]
34. TGIF1 splicing variant 8 is overexpressed in oral squamous cell carcinoma and is related to pathologic and clinical behavior.
Libório TN; Ferreira EN; Aquino Xavier FC; Carraro DM; Kowalski LP; Soares FA; Nunes FD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Nov; 116(5):614-25. PubMed ID: 24119525
[TBL] [Abstract][Full Text] [Related]
35. The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma.
Yang L; Wang Y; Guo L; Wang L; Chen W; Shi B
Biomed Res Int; 2015; 2015():637853. PubMed ID: 26523280
[TBL] [Abstract][Full Text] [Related]
36. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.
Hong Y; Miao X; Zhang X; Ding F; Luo A; Guo Y; Tan W; Liu Z; Lin D
Cancer Res; 2005 Oct; 65(20):9582-7. PubMed ID: 16230424
[TBL] [Abstract][Full Text] [Related]
37. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
[TBL] [Abstract][Full Text] [Related]
38. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Nakashiro K; Tanaka H; Goda H; Iwamoto K; Tokuzen N; Hara S; Onodera J; Fujimoto I; Hino S; Hamakawa H
Int J Oncol; 2015 Oct; 47(4):1273-81. PubMed ID: 26315674
[TBL] [Abstract][Full Text] [Related]
39. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
[TBL] [Abstract][Full Text] [Related]
40. [Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues].
Lü XZ; Zou YG; Yin XM; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1362-4. PubMed ID: 18753061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
